ScreenerHero

MAGLE Magle Chemoswed Holding AB (publ)

STO · SE · Healthcare · Biotechnology · maglegroup.com
0.4400SEK+7.32%Mkt Cap: 869069 $P/E: —

Magle Chemoswed Holding AB (publ) engages in researching, developing, and manufacturing in the areas of medicinal chemistry and pharmaceutical technology in Sweden, Switzerland, rest of Europe, the United States, Brazil,…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap869.07K USD
Enterprise Value33.51M USD
Revenue (TTM)26.38M USD
Gross Profit19.41M USD
Net Income (TTM)-24.08M USD
Revenue/Share13.39 SEK
Last Price0.4400 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees150
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.17
PEG—
EV/EBITDA7.78
EV/Revenue1.27
P/S0.03
P/B0.03
EPS (TTM)-8.23
EPS (Forward)2.40
52W Range
0.30801% of range22.80
52W High22.80 SEK
52W Low0.3080 SEK
Profitability
Gross Margin75.74%
Oper. Margin-20.26%
EBITDA Margin16.33%
Profit Margin-93.95%
ROE-84.05%
ROA-30.66%
Growth
Revenue Growth39.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.60M USD
CapEx (TTM)1.91M USD
FCF Margin54.28%
FCF Yield1647.46%
Net Debt32.70M USD
Net Debt/EBITDA7.59
Balance Sheet
Debt/Equity1.28
Current Ratio0.40
Quick Ratio0.19
Book Value/Sh12.61 SEK
Cash/Share0.10 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.000 SEK
Upside (mean)+127.3%
Target Range1.000 SEK – 1.000 SEK
# Analysts1
Ownership
Shares Out.20.65M
Float14.70M
Insiders0.00%
Institutions0.82%
Technical
SMA 500.4835 (-9.0%)
SMA 2005.008 (-91.2%)
Beta0.33
S&P 52W Chg16.45%
Avg Vol (30d)325.86K
Avg Vol (10d)889.75K
Technical Indicators
RSI (14)46.3
MACD-0.0254
MACD Signal-0.0043
MACD Hist.-0.0211
BB Upper1.137 SEK
BB Middle0.5474 SEK
BB Lower-0.0424 SEK
BB Width215.51%
ATR (14)0.2087 SEK
Vol Ratio (20d)0.31x